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Background: A growing body of research has demonstrated that impaired central pain modulation 
or central sensitization (CS) is a crucial mechanism for the development of persistent pain in chronic 
whiplash-associated disorders (WAD) and fibromyalgia (FM) patients. Furthermore, there is increasing 
evidence for cognitive dysfunctions among these patients. In addition, chronic WAD and FM patients 
often report problems with health-related quality of life (QoL). Yet, there is limited research concerning 
the interrelations between cognitive performance, indices of CS, and health-related QoL in these patients. 
Objectives: (1) Examining the presence of cognitive impairment, CS, and limitations on health-
related QoL in patients with chronic WAD and FM compared to healthy controls. (2) Examining 
interrelations between performance-based cognitive functioning, CS, and self-reported health-
related QoL in these 3 study groups. 
Study Design: A case-control study was conducted. 
Setting: The present study took place at the University Hospital Brussels, the University of Brussels, 
and the University of Antwerp.
Methods: Fifty-nine patients (16 chronic WAD patients, 21 FM patients, and 22 pain-free volunteers) 
filled out the Short Form 36 item Health Survey (SF-36), a self-reported psychosocial questionnaire, 
to assess health-related QoL. Next, they were subjected to various pain measurements (pressure 
hyperalgesia, deep-tissue hyperalgesia, temporal summation [TS], and conditioned pain modulation 
[CPM]). Finally, participants completed a battery of performance-based cognitive tests (Stroop task, 
psychomotor vigilance task [PVT], and operation span task [OSPAN]).
Results: Significant cognitive impairment, bottom-up sensitization, and decreased health-related 
QoL were demonstrated in patients with chronic WAD and FM compared to healthy controls (P 
< 0.017). CPM was comparable between the 3 groups. Cognitive performance was significantly 
related to central pain modulation (deep-tissue hyperalgesia, TS, CPM) as well as to self-reported 
health-related QoL (P < 0.05). Decreased cognitive performance was related to deficient central 
pain modulation in healthy controls. Further, significant correlations between decreased cognitive 
performance and reduced health-related QoL were revealed among all study groups. Additionally, 
FM patients showed correlations between cognitive impairment and increased health-related QoL. 
Remarkably, impaired selective attention and working memory were related to less TS, whereas 
impaired sustained attention was correlated with dysfunctional CPM in FM patients.
Limitations: Based on the current cross-sectional study no firm conclusions can be drawn on the 
causality of the relations.
Conclusion: In conclusion, this paper has demonstrated significant cognitive deficits, signs of CS, 
and reduced health-related QoL in chronic WAD and FM patients compared to healthy individuals. 
Significant relations between cognitive performance and CS as well as health-related QoL were 
demonstrated. These results provide preliminary evidence for the clinical importance of objectively 
measured cognitive deficits in patients with chronic WAD and FM. 
Key words: Chronic pain, fibromyalgia, whiplash, central sensitization, conditioned pain 
modulation, temporal summation, cognition, quality of life
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(21,25). Interestingly, it seems that activation of CPM 
is able to reduce TS among healthy pain-free individu-
als (26). By measuring both CPM, combined with the 
evaluation of enhanced TS, important information re-
garding central nervous systems’ pain modulation can 
be obtained. 
Apart from persistent pain, chronic WAD and FM 
patients often experience cognitive deficits, including 
concentration difficulties and working memory deficits 
(1,9,10,27). More specifically, the cognitive deficits en-
compass longer reaction times, short-term memory defi-
cits, and attention problems (28-30). Decreased cognitive 
function seems to be related to pain severity in various 
chronic pain populations (29,31), and is presumed to be 
a feature of CS (19). Accordingly, it is hypothesized that 
malfunctioning of endogenous pain inhibition and sub-
sequent chronic pain precludes optimal cognitive per-
formance. This hypothesis is supported by the findings 
of altered brain morphology (32,33) and brain activity 
(34,35) in patients with chronic WAD and FM. 
Besides the growing evidence for the above men-
tioned dysfunctions, studies examining the relation be-
tween objectively measured cognitive performance, CS, 
and health-related quality of life (QoL) in patients with 
chronic WAD and FM are limited (28). Accordingly, it is 
necessary to further investigate the possible relations 
between cognitive performance, CS, and health-related 
QoL in patients with chronic CS pain, like those with 
chronic WAD or FM. It is hypothesized that cognitive 
impairment is related to CS and increased limitations on 
health-related QoL.
Therefore, the aims of the current study are: 1) 
to compare these aspects between 2 patients groups 
characterized by CS, chronic WAD and FM, and healthy 
controls; and 2) to investigate the interrelations be-
tween cognitive performance, CS, and self-reported 
health-related QoL in patients with chronic WAD and 
FM, and healthy pain-free controls. 
2. Methods
2.1. Study Design and Setting
The present case-control study took place at the 
University Hospital Brussels, the University of Brussels, 
and the University of Antwerp. Participants received 
detailed study information and gave written informed 
consent prior to study enrollment. All patients and 
healthy control subjects were unpaid volunteers. This 
research was approved by the Ethics committee of the 
University Hospital Brussels.
1. IntroductIon
A whiplash injury is caused by a sudden acceler-
ation-deceleration of the head, mostly due to motor 
vehicle collisions (1,2). Up to 50% of whiplash patients 
develop chronic neck pain and disability (3,4). The term 
chronic whiplash-associated disorders (WAD) is used to 
describe the various symptoms that are experienced 
by whiplash patients beyond 3 months after the ac-
cident (1). These symptoms include persistent neck 
pain, referred pain, headache, dizziness, emotional and 
cognitive disturbance, and physical dysfunctions (5-7). 
Fibromyalgia (FM) is another condition characterized 
by various persistent symptoms (8). 
The diagnosis of FM is based upon the 1990 or 
2010 American College of Rheumatology (ACR) cri-
teria (9). According to these criteria, FM patients are 
characterized by chronic widespread musculoskeletal 
pain. Additionally, FM patients experience a variety of 
symptoms, including sleep disturbances, fatigue, cogni-
tive dysfunctions, and limitations in activities of daily 
living (8,10). Chronic pain is a predominant and com-
mon debilitating symptom in both patients with WAD 
and FM (11-13).
Nowadays, there is compelling evidence for im-
paired central pain modulation or central sensitization 
(CS) in both patients with chronic WAD and FM as the 
underlying mechanism of their pain complaints (11,13-
17). CS is defined as an exaggerated responsiveness of 
the central nervous system to a variety of stimuli, like 
pressure, temperature, light, and medication among 
others (18,19). The CS mechanism causes hyperalgesia, 
allodynia, temporal summation (TS), and referred pain 
across multiple spinal segments, leading to chronic 
widespread pain (11). The augmented excitability re-
sults in a largely decreased load tolerance of the neu-
romusculoskeletal system. Contiguously, it has been 
shown that alterations in descending pain pathways 
are involved in the CS process (20). Malfunctioning of 
descending neuronal pathways can lead to more facili-
tation and less inhibition of the transmitted nociceptive 
signals to the brain. 
The conditioned pain modulation (CPM) paradigm 
is often used to evaluate the efficacy of endogenous 
pain inhibition, and relies on the “pain-inhibits-pain” 
mechanism (21). Earlier studies provided evidence for 
inefficient CPM activation in patients with chronic 
WAD and FM (13,22-24). In addition, TS, defined as the 
increase in pain ratings after repetitive stimulation at 
a constant intensity, is widely used in pain research to 
assess hyperexcitability of the central nervous system 
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2.2. Participants and Assessments
The present study took place from July 2010 until 
December 2013. Sixteen patients with chronic WAD, 21 
patients with FM, and 22 healthy pain-free controls were 
included. Chronic WAD and FM patients were recruited 
in cooperation with rheumatologists and physical medi-
cine physicians. Eligible patients, men and women, were 
contacted by phone and/or email. In addition, patients 
were contacted using social network and Internet sites 
of chronic WAD and FM associations. Healthy controls 
were recruited through friends, relatives, or acquain-
tances of students, researchers, patients, and university 
staff. Each study participant had to be Dutch speaking 
and aged between 18 and 65 years. 
The chronic WAD group fulfilled the criteria of the 
Quebec Task Force (grade II to III) (1). Chronic neck pain 
due to a whiplash event was defined as pain lasting 
longer than 3 months. The FM group complied with the 
diagnostic criteria for FM as defined by the 1990 ACR (9). 
FM patients reporting a history of a whiplash trauma and 
chronic WAD patients fulfilling the diagnostic criteria for 
FM were excluded from the study. At the time of study 
participation, healthy individuals were not allowed to 
suffer from any pain complaints or any (chronic) disease. 
General exclusion criteria were neurologic, meta-
bolic, cardiovascular, or inflammatory disorders. In order 
to preclude confounding factors, pregnant women and 
women one year postnatal were excluded. Furthermore, 
all participants were asked to stop analgesics 48 hours 
prior to study participation, not to undertake physical 
exertion, and to refrain from consuming alcohol, caf-
feine, and nicotine on the day of the experiments.
2.3. Central Sensitization 
To investigate central pain modulation and the pres-
ence of CS, 4 critical aspects of the central pain system 
were assessed (36-39). First, in order to evaluate local 
and widespread hyperalgesia, pressure pain thresholds 
(PPTs) were measured with a digital algometer (Wagner 
Instruments, Greenwich, CT, USA) at symptomatic and 
remote areas. Secondly, deep-tissue hyperalgesia was 
evaluated. Thirdly, TS of pressure pain was examined. 
Finally, a CPM paradigm was conducted to assess the 
efficacy of endogenous pain inhibition.
2.3.1. Pressure Hyperalgesia
The PPT was measured at 2 different sites: the dorsal 
side of the intermediate phalanx of the right middle fin-
ger and the middle of the right trapezius belly, midway 
between the processus spinosus of the seventh cervical 
vertebra and the lateral edge of the acromion (40,41). 
On each site, 2 PPT measurements (interval 30 seconds) 
were performed, generating a mean PPT value per site. 
To determine the PPT, pressure was increased at a rate 
of approximately 1 kg/s and participants were asked to 
say “stop” at the moment the sensation became painful. 
Consequently, the pressure was immediately released. 
The pressure established on that moment was deter-
mined as the PPT, measured in kg/cm2. The use of pres-
sure algometry has been found to be an efficient and 
reliable technique in the determination of PPTs and sub-
sequently the examination of hyperalgesia (22,42,43).
2.3.2. Deep-tissue Hyperalgesia
Deep-tissue hyperalgesia was investigated by in-
flating an occlusion cuff placed around the left arm. 
The cuff served also as the conditioned stimulus in the 
CPM paradigm (see further). Cuff inflation rate was 
constant (20 mmHg/s) and manually increased until the 
participant reported pain. The pressure at this moment 
was registered (cuff pressure) and used for further data 
analyses. Participants then adapted to the stimulus for 
30 seconds and rated the pain on the verbal numeric 
rating scale (VNRS). Cuff inflation was then adjusted 
until participants indicated pain at a level 3 of 10 on 
the VNRS. Subsequent, this pressure (cuff pressure 
VNRS3) was stored and used for further data analyses.
2.3.3. Temporal Summation
TS was induced by means of a digital algometer 
(Wagner Instruments, Greenwich, CT, USA). TS was elic-
ited by 10 consecutive pressure pulses at PPT intensity 
on the same places. For each pulse of the TS procedure, 
the pressure was increased at a rate of 2 kg/s until the 
previously determined PPT, where it was maintained for 
one second before being released. Pressure pulses were 
presented with an inter-stimulus interval of one second. 
Participants were instructed to rate the pain intensity 
of the first, fifth, and tenth pressure pulse according to 
the VNRS. TS score was obtained by subtracting the first 
VNRS score from the last VNRS. The higher the TS score, 
the more efficient the nociceptive signaling to the brain. 
The TS procedure is found to be reliable and valid, and is 
supported to use in chronic pain patients (36).
2.3.4. Conditioned Pain Modulation
CPM was induced by inflating an occlusion cuff 
(conditioning stimulus) on the left arm, opposite of the 
test stimulus, to a painful intensity (see 2.3.2), being 
the TS procedure repeated while wearing the cuff. 
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The CPM procedure started when cuff inflation 
was adjusted equal to a level 3 of 10 on the VNRS. The 
left arm was then rested on a table while TS assessment 
was repeated at the right side as described above (36). 
Efficacy of CPM is examined by subtracting the 
VNRS at the first pressure pulse prior to and during cuff 
inflation (CPM). The efficacy of CPM on TS was assessed 
by subtracting TS of pressure pain (VNRS tenth pressure 
pulse) prior to and during cuff inflation (CPM on TS) 
(28). This CPM procedure is found to be reliable, and 
CPM induced by ischemic cuff inflation is able to reduce 
TS in healthy controls (36). 
2.4. Cognitive Performance
Cognitive performance was assessed using a 
battery of 3 consecutive computer tests: the Stroop 
task, the psychomotor vigilance task (PVT), and the 
operation span task (OSPAN). In order to standardize 
the procedure, each test began with the presentation 
of written instructions for that particular test. All study 
participants performed the cognitive tasks on the same 
computer and in a fixed order (i.e., Stroop task, PVT, 
and OSPAN). Each of the 3 tests has been used and de-
scribed in detail in 3 of our previous studies in patients 
with chronic CS pain (28,44,45).
2.4.1 The Stroop Task
The Stroop Task was used to evaluate selective atten-
tion, cognitive inhibition, and choice reaction time (46). 
Three different conditions were used, namely, “incon-
gruent” (word and ink color are different), “non word” 
(XXX in a specific color), and “negative priming” (e.g., 
the word green displayed in red immediately followed 
by the word blue displayed in green). 
Stroop reaction times for correct responses were 
taken into account for further analyses. Stroop inter-
ference effect was calculated by subtracting Stroop 
reaction time non-word from Stroop reaction time 
incongruent. Stroop interference seems to reflect one’s 
ability to inhibit irrelevant information, and is there-
fore a measure of cognitive inhibitory capacity.
Negative priming is defined as the condition 
where the to-be-ignored response in the first presen-
tation becomes the subsequent relevant dimension. 
Furthermore, negative priming is believed to rely on 
one of the mechanisms of selective attention (47). 
Hence, negative priming can provide more informa-
tion about the quality of cognitive control to select 
relevant information. 
2.4.2. The Psychomotor Vigilance Task
The PVT has been validated as a measure of sus-
tained attention, alertness, and simple reaction time 
(48). Participants were instructed to respond as quickly 
as possible to a visual stimulus (red spot on a black 
screen) presented at a variable time-interval (2,000 – 
10,000 ms). The trial was stored as a lapse, if a response 
had not been made within 500 ms. The PVT reaction 
time of correct responses and number of lapses were 
registered and used for statistical analyses. The PVT has 
good test-retest reliability for median response times 
(ICC = 0.89, P < 0.0001) and number of PVT lapses (ICC = 
0.83, P < 0.0001) (49).
2.4.3. The Operation Span Task
The OSPAN task was used to assess working mem-
ory capacity (50). The OSPAN task consisted of exercises 
on letter recall and math operation. The “Operation 
span” is the maximum number of letters that can be 
recalled. When the test was terminated, the “OSPAN 
total score” was retrieved and used for further statis-
tical analyses. The “OSPAN total score” is the sum of 
all perfectly recalled exercise sets. This score measures 
working memory capacity as it indicates the number of 
letters recalled in the correct position.
2.5. Self-reported Health-related QoL
The Short Form 36-item Health Survey (SF-36) was 
used to assess physical function, mental health, and 
health-related QoL (51). This self-reported question-
naire examines 2 main domains of health, namely the 
physical and mental component. Higher scores repre-
sent better health for that particular subitem. 
The SF-36 has been demonstrated to have good 
reliability and validity in chronic pain patients (51). 
2.6. Data Analysis
All statistical analyses were performed using IBM® 
SPSS® Statistics 22.0. Normality of variables was tested 
with the Shapiro-Wilk test and by visual evaluation of 
the histograms and QQ-plots. In addition, the Levene’s 
test examined equality of variance. The assumption of 
data normality and equality of variance was not ful-
filled. Accordingly, non-parametric tests were used for 
further data analyses. Comparability of groups for age, 
gender distribution, and disease duration was exam-
ined with the one-way ANOVA test and Chi-square test. 
First, the median values of the SF-36 questionnaire, 
pain measurements, and performance-based cognitive 
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tests were compared between the 3 study groups using 
the Kruskal-Wallis test. When a significance level of P < 
0.05 was found, the Mann-Whitney U test was performed 
for post-hoc comparisons. A significance level of P < 0.017 
(α < 0.05/3) was used (Bonferroni correction was applied 
to compensate for the multiple testing problem) and to 
maintain the initial significance level of α < 0.05. 
To determine the relationship between cognitive 
performance, CS, and health-related QoL, Spearman 
correlation coefficients were calculated between the 
results of the cognitive tests and central pain measures 
and SF-36 scores, respectively. 
3. results
3.1. Group Characteristics
The demographic characteristics of the 3 study 
groups are presented in Table 1. All study groups were 
comparable for age and sex distribution. Further, dis-
ease duration was not significantly different between 
the 2 patient groups. 
3.2 Comparison between Patients with 
Chronic WAD, FM, and Healthy Controls
3.2.1 Central Sensitization
Pressure hyperalgesia and deep-tissue hyperalgesia
Results of pressure and deep-tissue hyperalgesia 
are displayed in Table 2. PPTs at the shoulder and finger 
were significantly lower in FM patients compared to 
chronic WAD patients and controls. In addition, cuff 
pressures at the arm were significantly lower in the FM 
group compared to healthy participants. 
Temporal summation and conditioned pain 
modulation 
Results of TS prior to cuff inflation are shown in 
Table 2. No significant differences in TS were observed 
between chronic WAD and FM. In contrast, TS was sig-
nificantly higher in both patient groups in comparison 
with healthy controls. The 3 study groups displayed no 
significant differences for the efficacy of endogenous 
pain inhibition (CPM). 
3.2.2 Cognitive Performance
Table 3 presents the median and interquartile 
ranges (IQR) of the 3 performance-based cognitive tests 
and their subscales for the patients and controls. FM 
Table 1. Demographic characteristics of  the patients (cWAD and FM) and healthy controls.
Characteristics
cWAD
(n = 16)
FM
(n = 21)
CON
(n = 22)
P value
ANOVA
P value
Post-hoc Bonferroni
cWAD
vs FM
CON
vs cWAD
CON
vs FM
Age (y)b 41.62 (11.45) 44.52 (9.47) 38.00 (13.90) 0.202 1 1 0.227
Gender (male; female)c 3; 13 5; 16 8; 14 0.442
Disease duration (m)b 60.80 (69.70) 96.30 (73.10) 0 (0) < 0.001 0.219 0.004d < 0.001e
Occupational situationc
7 unemployed 16 unemployed 4 unemployed
1 part-time 2 part-time 4 part-time
8 full-time 3 full-time 9 full-time
0 student 0 student 5 student
Pain medication use (yes, no)C 0; 16 4; 17 1; 21 0.084
Antidepressant use (yes, no)C 4; 12 7; 14 1; 21 < 0.001
Other medication use (yes, no)C  0.448
Benzodiazepines & muscle relaxants 1; 15 1; 20 1; 21
Antihypertensive 0; 16 0; 21 3; 19
Medication for hyper- or hypothyrodism 1; 15 3; 18 0; 22
Medication for diabetes 1; 15 1; 20 0; 22
Anti-epileptic 0; 16 0; 21 1; 21 
A = Values are presented as means and SD for continuous data and as absolute frequencies for categorical data. 
B = Statistical analyses were performed using a one-way ANOVA. C = Statistical analyses were performed using a Pearson Chi-square test. d = 
Significant differences between cWAD patients and controls (P < 0.017). e = Significant differences between FM patients and controls (P < 0.017).
 y: years, m: months, cWAD: chronic whiplash-associated disorders, FM: fibromyalgia, CON: healthy controls
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patients presented impaired cognitive performance 
on all cognitive tests compared to healthy individuals. 
Chronic WAD patients only demonstrated impaired 
performance on the PVT test (significant longer PVT re-
action times and more PVT lapses) compared to healthy 
pain-free controls. 
3.2.3 Self-reported Health-related QoL
Median values and interquartile ranges (IQR) of 
the SF-36 total score, mental and physical health sum-
mary score are presented in Table 4. 
FM patients demonstrated higher limitations on all 
the SF-36 physical health domains compared to chronic 
WAD patients. In addition, both patient groups report-
ed significantly more problems on physical and mental 
health compared to healthy participants.
3.3 Relations between Cognitive 
Performance, CS, and Health-related QoL
3.3.1. Cognitive Performance and Central 
Sensitization
In the chronic WAD group, deep-tissue hyperalge-
sia was the only variable that significantly correlated 
(r = 0.517, P < 0.05) with cognitive performance, i.e. 
Stroop interference (data not shown). 
FM patients showed significant relations be-
tween cognitive performance and 4 measures of 
CS, as presented in Table 5. Longer Stroop reaction 
times and decreased recall capacities on the OSPAN 
were significantly correlated with lower TS scores. 
Further, an increased number of PVT lapses was 
significantly correlated with lower tolerable cuff 
pressure (VNRS3) and less efficient endogenous pain 
inhibition (CPM). 
In the healthy control group, longer Stroop and 
PVT reaction times were significantly related with re-
spectively, less CPM efficiency and lower cuff pressure 
(VNRS3) as demonstrated in Table 5.
Table 2. Comparison of  pressure hyperalgesia, deep-tissue hyperalgesia, temporal summation, and conditioned pain modulation 
between patients (cWAD and FM) and healthy controls.
Pain Measures
 cWAD (n = 16) FM (n = 21) CON (n = 22) Kruskal-Wallis Mann-Whitney U
 Median (IQR) Median (IQR) Median (IQR) P value < 0.05 P value < 0.017
Pressure and deep tissue hyperalgesia
PPT finger 7.70 (5.40 – 9.60)
3.00 
(1.89 – 5.68)
6.65 
(4.47 – 9.35) 0.002
FM < cWAD° ; 
FM < CON*
PPT shoulder 4.00 ( 2.50 –  5.20)
1.32 
(1.08 – 2.60)
4.22 
(2.99 – 5.80) 0.000
FM < cWAD° ; 
FM < CON*
Cuff pressure 160.00 (90.00 – 200.00)
80.00 
(63.00 – 145.00)
170 .00
(97.5 – 215) 0.018 FM < CON*
Cuff pressure (VNRS3) 110.00 (60.00 – 200.00)
63.00
 (42 – 90)
100.00 
(80 – 172) 0.020 FM < CON*
Temporal summation
TS finger 3.50 (2.00 – 5.00)
2.00 
(1.00 – 3.00)
2.00 
(1.00 – 3.00) 0.025 cWAD > CON**
TS shoulder 3.00 (2.00 – 4.00)
3.00 
(2.00 – 5.00)
1.00 
(0.00 – 3.00) 0.009
FM > CON*;
cWAD > CON**
Conditioned pain modulation
CPM finger (VNRS1) 0.00 (0.00 – 2.00)
0.00
 (0.00 – 1.00)
0 .00
(0.00 – 1.00) 0.620 ns
CPM shoulder (VNRS1) 1.00 (0.00 – 2.00)
0.00
 (- 0.75 – 1.00)
1.00
(0.00 – 2.00) 0.080 ns
CPM on TS finger (VNRS10) 1.00 (0.00 – 3.00)
0.00
(-0.37 – 1.00)
2.00 
(0.00 – 2.00) 0.070 ns
CPM on TS shoulder (VNRS10) 1.00 (0.00 – 2.50)
1.00
 (0.00 – 1.75)
1.00
 (0.00 – 2.00) 0.600 ns
Values are presented as median value and interquartile range (IQR). Significant differences are presented in bold font. PPT: Pressure pain thresh-
old, VNRS: Verbal numeric rating scale, TS: Temporal summation, CPM: Conditioned pain modulation, ns: not significant, cWAD: chronic whip-
lash-associated disorders, FM: fibromyalgia, CON: healthy controls. Significant differences (P < 0.017) between cWAD and FM are presented as (°) 
between CON and FM are presented as (*) between CON and cWAD are presented as (**).
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No significant relations were detected between 
cognitive performance and PPTs in the 3 study groups 
(data not shown).
3.3.2. Cognitive Performance and Health-
related QoL
The correlations between cognitive performance 
and SF-36 scores are presented in Table 6. In the chronic 
WAD group decreased cognitive performance was 
significantly related with reduced health-related QoL 
(SF-36). 
In the FM group a different pattern of correlations 
was seen. Stroop reaction times and interference were 
positively correlated with reduced QoL, whereas nega-
tive correlations were found between reduced QoL and 
PVT reaction times. 
Table 3. Comparison of  cognitive performance (Stroop Task, PVT, OSPAN) between patients (cWAD and FM) and healthy 
controls.
COGNITIVE TESTS
cWAD (n = 16) FM (n = 21) CON (n = 22) Kruskal-Wallis Mann-Whitney U 
Median (IQR) Median (IQR) Median (IQR) P value < 0.05 P value < 0.017
Stroop reaction times (ms)
Incongruent 1082.63 (977.52 – 1326.83)
1329.17 
(1134.53 – 1605.71)
998.53
(886.49 – 1157.48) 0.006 FM > CON*
Non-word 1014.61 (859.03 – 1134.20)
1226.52 
(1017.99 – 1384.80)
903.39 
(852.98 – 1095.35) 0.016 FM > CON*
Stroop Interference 127.79 (29.20 – 223.60)
143.53 
(65.14 – 194.91)
39.17 
(6.05  – 114.59) 0.025 FM > CON*
Priming negative 1063.11 (954.06 – 1572.11)
1333.89 
( 1168.65 – 1735.66)
983.55 
(884.11 – 1203.07) 0.018 FM > CON*
Psychomotor Vigilance Task
Reaction time (ms) 342.92 (319.50 – 382.43)
328.20 
(315.34 – 362.98)
298.05 
(281.96 – 315.88) 0.000
FM > CON; 
cWAD > CON
Lapses 12.50 (3.50 – 25.75)
10.50 
(6.00 – 15.00)
3.00 
(1.50 – 4.50) 0.001
FM > CON; 
cWAD > CON
Operation Span Task
OSPAN Total score 46.50 (15.50 – 55.50)
41.00 
(28.50 – 55.00)
55.00 
(49.00 – 64.00) 0.011
FM < CON*
Values are presented as median values and interquartile range (IQR). Significant differences are presented in bold font. cWAD: chronic whiplash-
associated disorders, FM: fibromyalgia, CON: healthy controls
Significant differences (P < 0.017) between cWAD and FM are presented as (°) between CON and FM are presented as (*)  between CON and 
cWAD are presented as (**).
Table 4. Comparison of  self-reported health-related QoL (SF-36) between patients (cWAD and FM) and healthy controls.
Values are presented as median values and interquartile range (IQR). Significant differences are presented in bold. 
SF-36: 36-Item Short-Form Health Survey, cWAD: chronic whiplash-associated disorders, FM: fibromyalgia, CON: healthy controls 
Significant differences (P < 0.017) between cWAD and FM are presented as (°); between CON and FM are presented as (*); between CON and 
cWAD are presented as (**).
SF-36 
QUESTIONNAIRE
cWAD 
(n = 16)
FM 
(n = 21)
CON
(n = 22)
Kruskal-Wallis Mann-Whitney U 
Median
(IQR)
Median
(IQR)
Median
(IQR)
P value <0.05 P value < 0.017
Quality of  life
Physical Health Total 167.50 (134.25 – 249.50)
116.00 
(76.00 – 152.50)
371.00 
(336.00 – 387.75) 0.000
FM < cWAD°; FM < CON*; 
cWAD < CON**
Mental Health Total 242.25 (150.96 – 291.50)
220.50
(159.83 – 264.00)
354.50 
(337.87 – 373.54) 0.000
FM < CON*; 
cWAD < CON **
SF-36 Total Score 414.25 (274.25 – 546.25)
338.00 
( 271.83 – 382.25)
728.00 
(662.25 – 748.25) 0.000
FM < CON*; 
cWAD < CON **
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Table 5. Spearman correlations between cognitive performance and pain measures in FM patients (n = 21) and healthy controls (n = 22).
StroopRT
incongruent
StroopRT
non-word
Stroop 
interference
StroopRT
priming neg.
PVT
RT
PVT 
LAPSES
OSPAN Total 
score
FM (n = 21)
TS finger -.341 -.402 -.303 -.155 .213 .054 .430
TS shoulder -.505* -.529* -.165 -.502* .197 -.034 .531*
Cuff pressure -.006 -.009 .082 -.006 -.152 -.501 .189
Cuff pressure (VNRS3) -.094 -.141 -.050 .201 -.371 -.625* -.089
CPM finger (VNRS1) -.053 -.100 .172 .142 -.214 -.648** -.065
CPM shoulder (VNRS1) -.463 -.467 -.334 -.089 .150 .099 -.187
CPM on TS fing .129 .092 .148 .393 -.240 -.427 .055
CPM on TS sh -.298 -.307 .064 -.089 -.194 -.530* .075
CON (n = 22)
TS finger -.253 -.234 -.328 -.275 -.112 -.232 .089
TS shoulder .045 .115 -.076 .020 .280 -.029 -.162
Cuff pressure -.189 -.279 .007 -.260 -.047 .208 .314
Cuff pressure (VNRS3) -.292 -.323 -.136 -.379 -.472* -.196 .368
CPM finger (VNRS1) -.304 -.321 -.298 -.379 -.307 .068 .292
CPM shoulder (VNRS1) -.579** -.539** -.448* -.622** -.387 -.375 .184
CPM on TS fing -.483* -.452* -.495* -.580** -.411 -.156 .261
CPM on TS sh -.214 -.132 -.227 -.146 -.217 -.370 .051
Significant correlations are presented in bold. * Correlation is significant at the 0.05 level (2-tailed). 
** Correlation is significant at the 0.01 level (2-tailed). VNRS: Verbal numeric rating scale, 
CPM: Conditioned pain modulation, TS: Temporal summation, RT: Reaction time, PVT: Psychomotor vigilance task, OSPAN: Operation Span 
Task, neg: negative, sh: shoulder, fing: finger
StroopRT
incongruent
StroopRT
non-word
Stroop
interference
StroopRT
priming neg.
PVT
RT
PVT
LAPSES
OSPAN
Total score
cWAD
Physical health total -.321 -.225 -.154 -.300 -.171 .084 -.301
Mental health total -.543* -.500 -.304 -.518* -.461 -.291 -.138
SF-36 Total score -.529* -.479 -.318 -.493 -.389 -.280 -.152
FM
Physic health total .535* .466 .595* .463 -.585* -.352 .038
Mental health total .147 .059 .277 .179 -.068 -.230 -.026
SF-36 Total score .355 .240 .505* .363 -.338 -.302 -.077
CON
Physical health total -.576** -.496* -.403 -.513* -.194 -.195 .172
Mental health total -.425* -.403 -.357 -.357 -.165 -.359 .076
SF-36 Total score -.468* -.472* -.489* -.159 -.176 .206
Table 6 .Spearman correlations between cognitive performance and health-related QoL in cWAD patients (n = 15), FM patients (n 
= 17), and healthy controls (n = 22).
Significant correlations are presented in bold. * Correlation is significant at the 0.05 level (2-tailed). 
** Correlation is significant at the 0.01 level (2-tailed).
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In the healthy control group decreased perfor-
mance on the Stroop was correlated with increased 
limitations on health-related QoL (SF-36). 
4. dIscussIon
The current study examined the presence of cogni-
tive impairment, signs of CS, and health-related QoL 
in chronic WAD and FM patients, compared to healthy 
controls. Secondly, this study is the first to examine 
interrelations between cognitive performance, indices 
of CS, and self-reported health-related QoL in these 2 
chronic pain populations. 
Central Sensitization
Remarkably, efficacy of endogenous pain inhibition 
(CPM) was comparable between the 3 study groups. Yet, 
previous studies have revealed dysfunctional CPM in pa-
tients with chronic WAD compared to healthy controls 
(26). Nevertheless, significant other features of CS were 
demonstrated in chronic WAD and FM patients compared 
to controls. First, enhanced TS was shown in both patient 
groups. These findings of enhanced TS in chronic WAD 
and FM are similar to previous studies (52,53). Second, sig-
nificant lower PPTs and decreased tolerable cuff pressures 
were revealed in FM patients compared to the other study 
groups, representing deep-tissue hyperalgesia at the arm 
in patients with FM but not in chronic WAD patients. In 
line with the results in the FM group, previous research 
has observed deep-tissue hyperalgesia among FM pa-
tients (48,54). The fact that no deep-tissue hyperalgesia 
was found among chronic WAD patients is in contrast 
with the results of Lemming et al (52), who demonstrated 
widespread deep-tissue hyperalgesia in patients with 
chronic WAD. However, the chronic WAD patients in the 
study of Lemming et al (52) experienced neck pain for at 
least 6 months and were recruited from a specific Pain 
and Rehabilitation Centre. Furthermore, deep-tissue hy-
peralgesia was measured with a computerized pneumatic 
cuff. Increased bottom-up sensitization, demonstrated 
by enhanced TS, was present in chronic WAD and FM pa-
tients compared to healthy controls. However, no signifi-
cant differences were found between the 3 study groups 
regarding CPM; hence, the present study could not un-
ravel impaired endogenous pain inhibition. In addition, 
FM patients demonstrated more pressure and deep-tissue 
hyperalgesia compared to chronic WAD patients. 
Further, prior research has established both pri-
mary and secondary hyperalgesia, demonstrated by 
decreased electrical pain thresholds at the neck and 
lower limb in chronic WAD patients (55). 
Cognitive Performance
The results of the current study showed longer 
choice and simple reaction times in patients with FM 
compared to controls, as evidenced by slower response 
times on the Stroop and PVT, respectively. Hence, FM 
patients demonstrated reduced selective and sustained 
attention. Furthermore, we revealed longer simple re-
action times in the chronic WAD group compared to 
controls. In addition, both patient groups showed sig-
nificantly more PVT lapses in comparison with healthy 
individuals. This indicates that chronic WAD and FM 
patients tend to make more errors of omission during 
the PVT cognition task. In addition, longer PVT reaction 
times point to the failure of sustained attention. 
An increased Stroop interference effect could not 
be demonstrated in the chronic WAD group, but the 
current study did however find significant increased 
interference and priming effect in FM patients relative 
to healthy controls. These results imply that chronic 
WAD patients are able to inhibit irrelevant informa-
tion, whereas FM patients seem to have problems with 
this attending ability. Increased interference effect or 
impaired cognitive inhibition has been demonstrated 
before in FM patients (56). In addition, significantly 
higher negative priming effects in FM patients were 
observed compared to controls. Therefore, this study 
provides preliminary evidence that FM patients experi-
ence problems with inhibiting distraction stimuli. 
Furthermore, no differences were found between 
chronic WAD patients and controls regarding Stroop 
reaction times. This indicates that chronic WAD patients 
have normal selective attention. As reported previously, 
chronic WAD patients presented only delayed informa-
tion processing when there was attentional bias, i.e., 
when sleep-related words were shown (28). On the con-
trary, the present study did demonstrate significantly 
longer Stroop reaction times in FM patients compared 
to healthy controls. The latter may indicate a general 
slowing down of information processing in patients 
with FM.
Regarding the OSPAN, chronic WAD patients 
showed normal working memory capacity. In contrast, 
FM patients established significant lower OSPAN scores 
compared to controls, illustrating reduced working 
memory capacity in FM patients. These findings are 
in line with accumulating evidence showing reduced 
working memory capacity in FM patients (57).
Self-reported Health-related QoL
The current study established significant limitations 
Pain Physician: May/June 2015; 18:E389-E401
E398  www.painphysicianjournal.com
on health-related QoL in patients with chronic WAD and 
FM compared to healthy controls. In particular, physical 
and mental health were impaired in these patients. Our 
results confirm current evidence of impaired physical 
and mental health in patients with chronic WAD and 
FM (58,59). Significantly worse scores in the FM group 
on domains of physical health were detected in com-
parison with chronic WAD patients. These results are 
in line with the literature, as FM patients score lower 
than other chronic pain conditions on health domains 
of bodily pain and vitality (58). 
In summary, FM patients demonstrated more signs 
of CS, higher cognitive impairment, and more physical 
health problems compared with chronic WAD patients. 
Possible explanations for the latter findings are the fact 
that the included FM patients experienced on average 3 
years longer disease symptoms compared to the chronic 
WAD patients. Additionally, it is reported that the med-
ical diagnosis of FM most often implies the presence of 
CS (11,60). In contrast, chronic WAD is associated but 
not uniformly characterized by CS (19).
Interrelations
Table 7 depicts a clinical useful translation of the 
observed correlations between cognitive impairment 
and respectively, impaired central pain modulation and 
health-related QoL limitations in the 3 study groups. 
Cognitive Performance and Central 
Sensitization
In the chronic WAD group, deep-tissue hyperalge-
sia was the only variable that significantly correlated 
to cognitive performance, i.e., cognitive inhibition. This 
finding suggests that deficits in cognitive inhibition 
are related to less deep-tissue hyperalgesia. However, 
malingering, headache, intelligence, and the degree of 
vigilance are possible factors influencing cognitive per-
formance in chronic WAD patients, and may explain the 
observed opposite relations (61). Possible explanations 
for the scarcely observed relations between cognitive 
performance and CS in chronic WAD patients are ob-
scure and merit further detailed research. 
In contrast, FM patients showed much more signifi-
cant relations between cognitive performance and vari-
ous indices of CS. In summary, impairment on the Stroop 
and OSPAN in FM patients was unexpectedly related to 
lower TS values, hence less bottom-up sensitization. Pos-
sibly, these results are due to an overall decreased vigilant 
state in FM patients for a variety of sensory input, e.g., 
pressure pulses. Subsequently, the sensory and nocicep-
tive transmission to the brain during the TS experiment 
could be delayed. On the other hand, in accordance with 
our expectations, impairment on the PVT was related to 
deficient CPM and increased deep-tissue hyperalgesia. 
Previous research has reported that working memory 
deficits in FM patients are related to grey matter volume 
changes in specific brain regions, which may indicate 
structural correlates of  pain-cognition interaction (33). 
In addition, it seems that chronic pain in FM patients dis-
rupts attention and induces neuroplasticity in the central 
nervous system (62).
In the healthy control group, less efficient pain 
inhibition was related to slower reaction times on the 
Stroop task. Furthermore, this is the first study finding 
a negative relation between PVT reaction times and 
deep-tissue hyperalgesia. 
The observations in healthy controls and part of 
the findings in FM patients are in line with our study 
hypothesis of expected correlations between decreased 
cognitive performance and increased indices of CS.
Cognitive Performance and Health-related 
QoL
In chronic WAD patients, correlations between 
impaired selective attention and lower health-related 
QoL, in particular mental health, were demonstrated. 
Impaired selective attention 
(Stroop)
Impaired sustained attention 
and reaction time (PVT)
Impaired working memory 
(OSPAN)
WAD FM CON WAD FM CON WAD FM CON
Deep-tissue hyperalgesia 1/∼ ∼ ∼
Increased TS 1/∼ 1/∼
Deficient CPM ∼ ∼
Reduced QoL  (SF-36) ∼ 1/∼ ∼ ∼ ∼ ∼ ∼
Table 7. Direction of  the correlations between cognitive impairment and respectively, impaired central pain modulation, and reduced 
health-related QoL.
1/∼: measurements are oppositely correlated, ∼: measurements are correlated in the same direction, QoL: Quality of Life
All measurements are presented in the impaired form. 
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These results are in line with our hypothesis and con-
sistent with earlier research that observed relations 
between psychological functioning and cognitive per-
formance in patients with chronic WAD (63).
A different pattern of correlations was obtained in 
the FM group. Remarkably, impaired selective attention 
and deficient cognitive inhibition were correlated with 
higher health-related QoL, whereas impaired sustained 
attention was related to increased QoL limitations. 
In the healthy control group, decreased selective 
attention and cognitive inhibition were related to 
lower health-related QoL. 
4.1. Study Strengths, Limitations and 
Recommendations for Further Research
The strengths of the present study are the inno-
vative aspect and the numerous observed significant 
correlations. Correlation coefficients which range from 
0.36 to 0.67 are generally believed to represent moder-
ate correlations (≤ 0.35 = weak correlation and 0.68 – 
1.0 = strong correlation) (64). In this study, all significant 
correlations (P < 0.05) were situated between the range 
of 0.42 and 0.82, thus moderate to strong correlations. 
When interpreting the results, the following study 
limitations have to be taken into account. Firstly, based 
on the current cross-sectional study, no firm conclusions 
can be drawn on the causality of the relations. In the 3 
study groups, longer reaction times were correlated 
with lower health-related QoL. However, it is uncertain 
if cognitive deficits lead to impaired QoL or vice versa. 
Moreover, malingering, concentration, education level, 
and IQ could have influenced the cognitive study results. 
Secondly, when conducting this study various confound-
ers, including medication use were taken into account. 
However, it has to be noticed that antidepressiva use was 
significantly different between the 3 study groups. In ad-
dition, we cannot exclude possible differences in educa-
tion level or other biopsychosocial characteristics between 
the patients and controls and that this may have created 
bias in the results. Thirdly, only non-parametric statistical 
analyses were performed because the sample size of the 
current study was rather small. 
Consequently, further research is warranted to in-
vestigate if CS and reduced health-related QoL lead to 
cognitive impairment or vice versa. 
5. conclusIon
In conclusion, chronic WAD and FM patients en-
counter significant cognitive impairment, signs of CS, 
and decreased health-related QoL compared to healthy 
pain-free individuals. The current study revealed more 
indices of CS, higher cognitive impairment, and more 
limitations on health-related QoL in FM patients com-
pared with chronic WAD patients. In particular, FM 
patients showed higher impairment of self-reported 
physical health, pressure and deep-tissue hyperalgesia, 
hampered selective attention, and reduced working 
memory capacity in comparison with chronic WAD 
patients. 
Significant correlations between cognitive impair-
ment and indices of CS and self-reported health-related 
QoL, respectively, were demonstrated among the 3 
study groups. Especially in FM patients cognitive impair-
ment appeared to be related to indices of CS. Reduced 
selective and sustained attention, as well as reduced 
working memory were correlated with less TS, so less 
bottom-up sensitization in FM. However, impaired sus-
tained attention was related to increased deep-tissue 
hyperalgesia, deficient CPM, and reduced QoL in FM 
patients. 
Accordingly, these results provide preliminary 
evidence for the clinical importance of objectively mea-
sured cognitive deficits in patients with chronic WAD 
and FM and the relation with CS in FM. Furthermore, 
in both patient groups there are distinct relations be-
tween self-reported health-related QoL and cognitive 
performance, albeit the specific cause-effect relation-
ship remains unclear and requires further research.
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